Neuromodulation market is expected to grow at a significant rate during the forecast period 2019-2025. Neuromodulation uses pharmaceutical agents, electrical signals, or other forms of energy for stimulating nerves by modulating abnormal neural pathway behavior caused by the disease. The neuromodulation treatment approach involves non-invasive techniques such as transcranial magnetic stimulation as well as implanted devices including spinal cord stimulation or a deep brain stimulation system. The global neuromodulation market is estimated to grow at a significant rate during the forecast period.

The major factor that is contributing to the growth of the global neuromodulation market includes the increasing prevalence of neurological disorder. In addition, the rapid rise in the geriatric population pool further boosts the growth of the global neuromodulation market, as this population pool is more vulnerable to neurological disorders such as Alzheimer’s disease. Further, increasing awareness regarding the safety and efficacy of neurostimulator devices is also surging the growth of the global neuromodulations market. However, factors such as stringent government regulations, and a dearth of trained healthcare professionals serve as the major barriers in the growth of the market across the globe.

The global neuromodulation market is segmented on the basis of technology, application, and region. On the basis of technology, the market is further diversified into internal neuromodulation and external neuromodulation. Internal neuromodulation includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES), while external neuromodulation includes transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES). Moreover, on the basis of application, the market is further segmented into chronic pain, Parkinson’s disease, OCD, TRD, urinary and fecal disorder, and others.

Geographically, the market is analyzed into North America, Europe, Asia-Pacific and Rest of the World. Among these, North America is estimated to hold a significant share owing to the presence of a large population pool suffering from neurological disorders. In addition, the presence of major market players such as Abbott Laboratories Inc., and Boston Scientific Corp. further fuel the growth of the North American neuromodulation market. Moreover, Asia-Pacific is estimated to exhibit a significant growth rate during the forecast period owing to the increasing geriatric population in the region. Further, improving the healthcare infrastructure of the region also contribute to the growth in the Asia-Pacific region.

The global neuromodulation market is dominated by some of the major players operating in the market. The major player operating in the market include Medtronic PLC, Boston Scientific Corp., Abbott Laboratories Inc., Synapse Biomedical Inc., Nevro Corp. These players adopt various strategies such as merger & acquisition, product launch, and partnership & collaboration to sustain in the competitive market.

Research Methodology

The market study of the global neuromodulation market is incorporated by extensive primary and secondary research conducted by a research team at OMR.  Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include

• Financial reports of companies involved in the market
  
• Authentic Public Databases such as the National Institute of Health and International Neuromodulation Society.
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog

The report is intended for neurostimulator devices manufacturers, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

Global Neuromodulation Market Research and Analysis by Technology

Global Neuromodulation Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the global neuromodulation market.
  
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global neuromodulation market.
• Insights about market determinants which are stimulating the global neuromodulation market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.